Clark BZ - Search Results

1

Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?

Yu J, da Silva EM, La HS, Clark BZ, Fine JL, Carter GJ, Villatoro TM, Soong TR, Lee AV, Oesterreich S, Basili T, Blanco-Heredia J, Selenica P, Ye Q, Da Cruz Paula A, Dopeso H, Gazzo A, Marra A, Pareja F, Reis-Filho JS, Bhargava R. Yu J, et al. Among authors: clark bz. NPJ Breast Cancer. 2023 Jul 13;9(1):60. doi: 10.1038/s41523-023-00566-7. NPJ Breast Cancer. 2023. PMID: 37443169 Free PMC article.

2

Impact of progesterone receptor semiquantitative immunohistochemical result on Oncotype DX recurrence score: a quality assurance study of 1074 cases.

Clark BZ, Dabbs DJ, Cooper KL, Bhargava R. Clark BZ, et al. Appl Immunohistochem Mol Morphol. 2013 Jul;21(4):287-91. doi: 10.1097/PAI.0b013e31826f80c9. Appl Immunohistochem Mol Morphol. 2013. PMID: 23060300

3

Bright-field microscopy for HER2 gene assessment: not just DISH-ful thinking?

Clark BZ, Bhargava R. Clark BZ, et al. Am J Clin Pathol. 2013 Feb;139(2):137-9. doi: 10.1309/AJCP26LRFURXTOBO. Am J Clin Pathol. 2013. PMID: 23355196 No abstract available.

4

Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas.

Clark BZ, Beriwal S, Dabbs DJ, Bhargava R. Clark BZ, et al. Am J Clin Pathol. 2014 Jul;142(1):64-71. doi: 10.1309/AJCP8H2VBDSCIOBF. Am J Clin Pathol. 2014. PMID: 24926087

5

Immunohistochemical profile of breast cancer with respect to estrogen receptor and HER2 status.

Gloyeske NC, Woodard AH, Elishaev E, Yu J, Clark BZ, Dabbs DJ, Bhargava R. Gloyeske NC, et al. Among authors: clark bz. Appl Immunohistochem Mol Morphol. 2015 Mar;23(3):202-8. doi: 10.1097/PAI.0000000000000076. Appl Immunohistochem Mol Morphol. 2015. PMID: 25356941

6

Molecular drivers of lobular carcinoma in situ.

Logan GJ, Dabbs DJ, Lucas PC, Jankowitz RC, Brown DD, Clark BZ, Oesterreich S, McAuliffe PF. Logan GJ, et al. Among authors: clark bz. Breast Cancer Res. 2015 Jun 4;17:76. doi: 10.1186/s13058-015-0580-5. Breast Cancer Res. 2015. PMID: 26041550 Free PMC article. Review.

7

Pathologist's health-care value in the triage of Oncotype DX^® testing: a value-based pathology study of tumour biology with outcomes.

Dabbs DJ, Clark BZ, Serdy K, Onisko A, Brufsky AM, Smalley S, Perkins S, Bhargava R. Dabbs DJ, et al. Among authors: clark bz. Histopathology. 2018 Oct;73(4):692-700. doi: 10.1111/his.13690. Epub 2018 Aug 6. Histopathology. 2018. PMID: 29920746

8

High Fidelity of Breast Biomarker Metrics: A 10-Year Experience in a Single, Large Academic Institution.

Zhang H, Han M, Varma KR, Clark BZ, Bhargava R, Dabbs DJ. Zhang H, et al. Among authors: clark bz. Appl Immunohistochem Mol Morphol. 2018 Nov/Dec;26(10):697-700. doi: 10.1097/PAI.0000000000000697. Appl Immunohistochem Mol Morphol. 2018. PMID: 30095467

9

Breast cancer global tumor biomarkers: a quality assurance study of intratumoral heterogeneity.

Clark BZ, Onisko A, Assylbekova B, Li X, Bhargava R, Dabbs DJ. Clark BZ, et al. Mod Pathol. 2019 Mar;32(3):354-366. doi: 10.1038/s41379-018-0153-0. Epub 2018 Oct 16. Mod Pathol. 2019. PMID: 30327501 Free article.

10

Breast Cancers With Magee Equation Score of Less Than 18, or 18-25 and Mitosis Score of 1, Do Not Require Oncotype DX Testing: A Value Study.

Bhargava R, Clark BZ, Dabbs DJ. Bhargava R, et al. Among authors: clark bz. Am J Clin Pathol. 2019 Feb 4;151(3):316-323. doi: 10.1093/ajcp/aqy148. Am J Clin Pathol. 2019. PMID: 30395177 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page